Lv42
430 积分 2023-04-19 加入
The expression of VEGF and Dll4/Notch pathway molecules in ovarian cancer
8小时前
待确认
Elevated DLL4 expression is correlated with VEGF and predicts poor prognosis of nasopharyngeal carcinoma
8小时前
已完结
The present and future of bispecific antibodies for cancer therapy
1天前
已完结
The inhibition of endothelial DLL4-NOTCH1 signaling by 2'-hydroxyflavanone enhances anti-PD-1 therapy in melanoma
15天前
已完结
Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity
15天前
已完结
Engineering bispecific T-cell engagers to deplete eosinophils for the treatment of severe eosinophilic asthma
16天前
已完结
IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer
18天前
已完结
T cell exhaustion
22天前
已完结
Reducing affinity as a strategy to boost immunomodulatory antibody agonism
26天前
已完结
Engineering CD3/CD137 dual specificity into a DLL3-targeted T-cell engager enhances T-cell infiltration and efficacy against small cell lung cancer
4个月前
已完结
皖公网安备34019202002308
